Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2171| Title: | Can antipsychotic medication administered for paediatric emotional and behavioural disorders lead to brain atrophy? | Authors: | Bastiampillai, T. Allison, S. Parry, P. |
Issue Date: | 2019 | Source: | 53, (6), 2019, p. 499-500 | Pages: | 499-500 | Journal: | Australian and New Zealand Journal of Psychiatry | Abstract: | L6260275192019-01-24 | DOI: | 10.1177/0004867418797419 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L626027519&from=exporthttp://dx.doi.org/10.1177/0004867418797419 | | Keywords: | drug efficacy;drug exposure;drug safety;editorial;emotional disorder;frontal cortex;frontal lobe;health survey;human;nonhuman;nuclear magnetic resonance imaging;obesity;parietal lobe;prescription;schizophrenia;substance abuse;oppositional defiant disorder;haloperidolneuroleptic agent;olanzapine;attention deficit hyperactivity disorder;autism;behavior disorder;brain atrophy;brain function;brain region;brain size;child psychiatry;conduct disorder;diabetes mellitus;disease duration;disease severity;drug effect | Type: | Article |
| Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.